Mouse strains influence clearance and efficacy of antibody and antibody–drug conjugate via Fc–FcGR interaction

36Citations
Citations of this article
87Readers
Mendeley users who have this article in their library.
Get full text

Abstract

To provide a better understanding of the pharmacokinetics–pharmacodynamics relationships of antibody-based drugs, we analyzed several chimeric and humanized monoclonal antibodies or antibody–drug conjugates (ADC) for PK and efficacy among four strains of mice. Notably, antibodies and ADCs displayed a dose-dependent drug disposition profile in the plasma of NSG mice. The increased clearance rate in NSG mice resulted in the reduction of antitumor activity of ADCs. Furthermore, we identified that the abnormal clearance was mediated by Fc–FcgR interaction by comparing antibodies that lack FcgR binding capacity. We also found a high percentage of FcgR-expressing macrophages in the bone marrow, spleen, and liver of NSG mice, which may be responsible for the abnormal distribution of antibodies. Overall, these findings suggest that preclinical evaluation of efficacy and pharmacokinetics of antibodies and ADCs need to consider mouse strain-induced variations.

Cite

CITATION STYLE

APA

Li, F., Ulrich, M. L., Shih, V. F. S., Cochran, J. H., Hunter, J. H., Westendorf, L., … Benjamin, D. R. (2019). Mouse strains influence clearance and efficacy of antibody and antibody–drug conjugate via Fc–FcGR interaction. Molecular Cancer Therapeutics, 18(4), 780–787. https://doi.org/10.1158/1535-7163.MCT-18-0977

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free